These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16006127)

  • 21. The pharmacology and clinical use of caspofungin.
    Hope WW; Shoham S; Walsh TJ
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug.
    J Assoc Nurses AIDS Care; 2001; 12(4):93-4. PubMed ID: 11486726
    [No Abstract]   [Full Text] [Related]  

  • 23. Caspofungin: an echinocandin antifungal agent.
    Stone EA; Fung HB; Kirschenbaum HL
    Clin Ther; 2002 Mar; 24(3):351-77; discussion 329. PubMed ID: 11952021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
    Kulemann V; Bauer M; Graninger W; Joukhadar C
    Pharmacology; 2005 Dec; 75(4):165-78. PubMed ID: 16192747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Schäfer-Korting M
    Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of caspofungin and the echinocandins in the antifungal armamentarium.
    Morrison VA
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1432-6. PubMed ID: 12431014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiences with the use of caspofungin in paediatric patients.
    Lehrnbecher T; Groll AH
    Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of caspofungin in HIV-infected individuals.
    Waters L; Nelson M
    Expert Opin Investig Drugs; 2007 Jun; 16(6):899-908. PubMed ID: 17501701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK.
    Bruynesteyn K; Gant V; McKenzie C; Pagliuca T; Poynton C; Kumar RN; Jansen JP
    Eur J Haematol; 2007 Jun; 78(6):532-9. PubMed ID: 17419744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anidulafungin: a new echinocandin for the treatment of fungal infections.
    Cohen-Wolkowiez M; Benjamin DK; Steinbach WJ; Smith PB
    Drugs Today (Barc); 2006 Aug; 42(8):533-44. PubMed ID: 16969430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of topical caspofungin in experimental fusarium keratitis.
    Ozturk F; Yavas GF; Kusbeci T; Cetinkaya Z; Inan UU; Ermis SS; Kiraz N
    Cornea; 2007 Jul; 26(6):726-8. PubMed ID: 17592325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
    Glasmacher A; Cornely OA; Orlopp K; Reuter S; Blaschke S; Eichel M; Silling G; Simons B; Egerer G; Siemann M; Florek M; Schnitzler R; Ebeling P; Ritter J; Reinel H; Schütt P; Fischer H; Hahn C; Just-Nuebling G
    J Antimicrob Chemother; 2006 Jan; 57(1):127-34. PubMed ID: 16308418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.
    Makowsky MJ; Warkentin DI; Savoie ML
    Ann Pharmacother; 2005; 39(7-8):1365-6. PubMed ID: 15956243
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections.
    Sanz-Rodriguez C; Lopez-Duarte M; Jurado M; Lopez J; Arranz R; Cisneros JM; Martino ML; Garcia-Sanchez PJ; Morales P; Olivé T; Rovira M; Solano C
    Bone Marrow Transplant; 2004 Jul; 34(1):13-20. PubMed ID: 15122312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation.
    Pancham S; Hemmaway C; New H; Albert E; Dokal I; Roberts IA; McCloy M
    Pediatr Transplant; 2005 Apr; 9(2):254-7. PubMed ID: 15787803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micafungin (Mycamine) for fungal infections.
    Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of caspofungin against Aspergillus terreus.
    Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Fallani S; Manso E; Pisa E; Giannini D; Novelli A; Cassetta MI; Mazzei T; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5133-5. PubMed ID: 16304185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.